Forbes

Novartis Calls Wonder Woman

Novartis ' Zelnorm, approved by U.S. regulators in July, could well reach annual sales of $1 billion or more. But in order for that to happen, Novartis has to convince gun-shy doctors that the drug is ...
Los Angeles Times

FDA Says Novartis Drug Ad Is Misleading

U.S. regulators told Novartis to discontinue a print ad that allegedly overstated the benefits of irritable bowel drug Zelnorm and omitted important safety information. The ad did not mention the drug ...
Medscape

Marketing of Zelnorm Suspended; Drug Linked to Slight Increase in CV Events

March 30, 2007 (East Hanover, NJ) - Novartis, in compliance with an FDA request, has suspended marketing and sales of its irritable bowel/constipation drug Zelnorm (tegaserod maleate), after an ...
Yahoo Finance

Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the Promotion of ZELNORM® to Healthcare Professionals in the United States

BEDMINSTER, N.J., July 23, 2020 (GLOBE NEWSWIRE) -- Alfasigma USA, Inc. today announced a strategic deal with Indegene, Inc., a global life sciences and healthcare solutions provider, to co-promote ...
MarketWatch

Novartis suspends sales of Zelnorm in U.S. on FDA request

BASEL (MarketWatch) -- Novartis AG NVS Friday said it will suspend sales and marketing for its irritable bowel drug Zelnorm after the U.S. Food and Drug Administration asked for more discussion on the ...